Related Experiment Video
Updated: May 16, 2026
09:29
Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
Molecular pathogenesis of neuromyelitis optica
Wajih Bukhari1, Michael H Barnett, Kerri Prain
1School of Medicine, Gold Coast Campus, Griffith University, QLD 4222, Australia. w.bukhari@griffith.edu.au.
International Journal of Molecular Sciences
|December 4, 2012
Summary
Neuromyelitis optica (NMO) is an autoimmune disease targeting aquaporin-4 (AQP4) water channels in the central nervous system. Understanding NMO IgG
Area of Science:
- Neuroimmunology
- Autoimmune Disorders
- Central Nervous System Pathology
Background:
- Neuromyelitis optica (NMO) is a rare autoimmune disorder affecting optic nerves and spinal cord.
- NMO is distinct from multiple sclerosis, characterized by inflammation and lesions.
- An autoantibody, NMO IgG, targeting aquaporin-4 (AQP4) on astrocytes is considered causative.
Purpose of the Study:
- To elucidate the pathogenesis of Neuromyelitis Optica (NMO).
- To understand the role of anti-aquaporin-4 (AQP4) antibodies in NMO.
- To explore mechanisms underlying NMO pathogenesis, including seronegative cases.
Main Methods:
- Investigated the role of anti-AQP4 antibodies in central nervous system (CNS) damage.
- Examined complement-mediated cytotoxicity against astrocytes expressing AQP4.
- Considered the involvement of Th17 cells and associated cytokines in disease mechanisms.
Main Results:
- Anti-AQP4 antibodies cause astrocytic loss in specific CNS regions via complement-mediated cytotoxicity.
- Demyelination is a secondary event, likely due to oligodendrocyte apoptosis from astrocyte damage.
- Extensive axonal injury results in severe neurological disability.
Conclusions:
- Neuromyelitis optica pathogenesis involves anti-AQP4 antibodies targeting astrocytes in the CNS.
- Complement-mediated cytotoxicity and secondary demyelination contribute to disease progression.
- Further research is needed to address unanswered questions, especially in NMO IgG seronegative cases.
Related Concept Videos
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:26Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...